DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Arihant Capital Markets Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 3 hrs ago·14 Oct 2026, 2:05 pm

Arihant Capital Mkts

Arihant Capital Markets Limited has received a certificate from the Securities and Exchange Board of India (SEBI) under the Depositories and Participants Regulations, 2018. This regulatory milestone signifies that the company has successfully met the necessary requirements to operate as a Depository Participant (DP).

For investors, this development is a positive signal, as it confirms the company's compliance with essential market infrastructure rules. It enhances the credibility of the firm's operations and assures clients that their securities are being handled by a registered entity.

Investors should monitor the company’s future announcements regarding the expansion of its DP network and client acquisition. These factors will be key in understanding how this regulatory approval impacts the firm's operational growth and market standing.